Pricey Biogen 401(k) Plan Was 'Glaring Breach,' Suit Says
Drugmaker Biogen Inc. saddled employees with high-cost, underperforming mutual funds through its Fidelity-managed retirement plan in a "glaring breach" of fiduciary duty, according to a proposed class action suit filed Monday...To view the full article, register now.
Already a subscriber? Click here to view full article